Polen Capital Management LLC bought a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 7,906,255 shares of the company’s stock, valued at approximately $718,995,000. Novo Nordisk A/S accounts for about 1.9% of […]